Close Menu

Grace Terrell

Mar 22, 2017

Envision Genomics has appointed Grace Terrell as founding CEO. Terrell most recently served as the founder and strategist for Cornerstone Health Enablement Strategic Solutions, which she founded in 2012. She concurrently served as CEO of Cornerstone Health Care from 2000 to 2016, and is a practicing internist at Cornerstone Health Care.

More Like This

Apr 15, 2021

Inflammatix: Amy Boyle

Inflammatix has appointed Amy Boyle as its chief operating officer. Boyle has 30 years of commercial medical device experience, with expertise in strategy, market development, sales and marketing, commercial operations, and manufacturing.

Most recently, she served as vice president, strategy, planning, and marketing for the health solutions division of Flex. Prior to that, she was vice president, marketing for the urology division of Coloplast, where she led global expansion and growth of the surgical urology business, and launched the firm's endourology portfolio in the US.

Previously, Boyle was executive vice president of marketing for Imris and spent five years at St. Jude Medical, first as vice president, marketing, international, responsible for cardiovascular businesses, and then as vice president, corporate brand and marketing. She also spent 17 years with Medtronic in Canada and the US in a variety of sales roles, including regional vice president of sales for the cardiac rhythm management business.

Apr 15, 2021

Specific Diagnostics: Scott Wehage

Specific Diagnostics has appointed Scott Wehage the company's director of US clinical trials. He was previously clinical project manager for Becton Dickinson's global clinical development department and oversaw clinical trials for device and in vitro diagnostic product development. Prior to that, he was a program manager at Johns Hopkins University. Based in Mountain View, California, Specific Dx has developed an IVD system leveraging a metabolomic signature technology that allows for the detection and identification of microorganisms as they grow in culture. The first commercial application of the technology will be for the determination of antibiotic susceptibility.

Apr 13, 2021

Sera Prognostics: Benjamin Jackson

Benjamin Jackson has been appointed as general counsel of Sera Prognostics. He joins the Salt Lake City-based pregnancy health company from Myriad Genetics, where he held the same position.

Apr 13, 2021

ARUP Labs: Sherrie Perkins, Andy Theurer, Tracy George

Sherrie Perkins is retiring as CEO of ARUP Laboratories, effective June 30. Andy Theurer, ARUP's president, has been appointed by the board to replace Perkins. Tracy George will become ARUP's president and remain as its CMO, the Salt Lake City-based company said.

Perkins is a hematopathologist and joined ARUP in 1990 as a fellow, becoming its CEO in 2017. Theurer has been at ARUP for more than 30 years and was its senior vice president and CFO before becoming its president in 2017. He has been on ARUP's executive committee and a board member for more than 20 years, ARUP said. George is a hematopathologist and has been ARUP's CMO since last September. She joined the firm in 2018 as executive director of clinical trials and pharmaDx. Prior to joining ARUP, she was chief of hematopathology at TriCore Reference Laboratories. She was also vice chairwoman of clinical affairs at the University of New Mexico department of pathology.

Apr 12, 2021

ACMG: Susan Klugman, Shweta Dhar, Hutton Kearney, David Stevenson, Jerry Vockley

The American College of Medical Genetics and Genomics has added five new members to its board of directors, including its new president-elect. They will serve six-year terms starting this month.

Susan Klugman is ACMG's president-elect. She is the director of the division of reproductive and medical genetics at Albert Einstein College of Medicine and Montefiore Medical Center. Klugman holds an a bachelor of science in biometry and statistics from Cornell University and an MD from New York University School of Medicine. She is board certified in clinical genetics and in obstetrics and gynecology.

Shweta Dhar is an associate professor in the department of molecular and human genetics and the department of internal medicine at Baylor College of Medicine. She is a graduate of Nathiba Hargovandas Lakhmichand Municipal Medical College in India and holds an MS in biotechnology from Stephen F. Austin State University in Texas. She is board certified in clinical genetics and internal medicine.

Hutton Kearney is vice chair of hereditary genomics in the Mayo Clinic Division of Laboratory Genetics and Genomics and an assistant professor of laboratory medicine and pathology. She holds a BS in secondary education from Auburn University and a PhD in genetics and molecular biology from the University of North Carolina at Chapel Hill. She is board certified in clinical cytogenetics and clinical molecular genetics.

David Stevenson is a professor of pediatrics in the division of medical genetics at Stanford University. He holds a BA in biology from Utah State University and an MD from the University of Utah.

Jerry Vockley is chief of the division of medical genetics and director of the Center for Rare Disease Therapy at UPMC Children's Hospital of Pittsburgh. He holds an undergraduate degree from Carnegie Mellon University as well as an MD and a PhD in genetics from the University of Pennsylvania School of Medicine. He is board certified in clinical genetics and in clinical biochemical/molecular genetics.

Apr 12, 2021

Castle Biosciences: Kristen Oelschlager

Castle Biosciences has appointed Kristen Oelschlager as chief operating officer. Oelschlager had been serving as the company's chief operations officer since August 2020. Prior to that, she served as senior vice president of clinical operations from January 2018 to August 2020, VP of clinical operations from 2013 to 2018, and executive director of operations from October 2008 to 2013.
Oelschlager also served as director of clinical research for Arizona Pulmonary Specialists from May 1996 to September 2008.
Apr 09, 2021

Micronoma: Jennifer Wargo

Micronoma, a company using signals from the tumor-related microbiome for liquid biopsy-based cancer diagnosis, has appointed Jennifer Wargo to its scientific advisory board. Wargo is a professor of surgical oncology and genomic medicine at the University of Texas MD Anderson Cancer Center.

Apr 05, 2021

Quadrant Biosciences: Brady Millican

Quadrant Biosciences announced Brady Millican has joined the firm as executive VP of sales. He has more than 30 years of experience in sales, marketing, business development, and operations in the medical diagnostics and prognostics space and was most recently chief business officer of Admera Health. Before that, he had senior level sales and marketing positions at Bostwick, Ameripath, and Dianon Laboratories. Based in Syracuse, New York, Quadrant has developed Clarifi ASD, a molecular saliva-based test for autism spectrum disorder, as well as Clarifi COVID-19, a saliva-based test codeveloped with the SUNY Upstate Medical University, which received Emergency Use Authorization from the US Food and Drug Administration in September.

Apr 05, 2021

Akoya Biosciences: Frederick Pla

Akoya Biosciences has appointed Frederic Pla as its chief operating officer. Pla most recently served as chief operating officer at the Parker Institute for Cancer Immunotherapy. Prior to this, Pla served as COO at Genomic Health before its acquisition by Exact Sciences in 2019. He has also served in leadership positions at Life Technologies, GE Healthcare, and NASA.

Mar 31, 2021

Group K Diagnostics: Jay Rosan, Scientific Advisory Baord

Group K Diagnostics has appointed Jay Rosan to its board of directors. He was VP of health innovation for Walgreens. The company also said that it formed a scientific advisory board in late 2020 comprising Francis Waller, Mark Wingertzahn, Peter Fisher, and Patrick Connolly.

Mar 31, 2021

CareDx: Titte Srinivas, Steven Stone, Dustin Leach, Martyn Edney, More

CareDx has appointed Titte Srinivas as vice president of digital development and clinical integration, Steven Stone as VP of KidneyCare, Dustin Leach as VP of customer experience, and Martyn Edney as senior VP and head of human resources.

Srinivas is a transplant nephrologist who joins CareDx from University Hospitals in Cleveland, where he served as the chief of the division of nephrology and hypertension and Peter B. DeOreo Chair in Nephrology and Dialysis. Stone joins CareDx from from Myriad Genetics, where he served as VP of cancer genomics and developed products for personalized medicine in oncology. Leach joins CareDx from Teva Pharmaceuticals, where he most recently served as senior director of patient services – program development. Edney joins CareDx from Iqvia, where he served as VP of HR for the US and Canada.

The company also announced that it has promoted Marica Grskovic to VP of cell transplant therapy, and Jere Ramsey-Lester to VP of HR.

Grskovic joined CareDx nine years ago and has played a role in overseeing the design and development of the company's transplant diagnostic tests. Ramsey-Lester has been with CareDx since 2019, and has served as interim head of HR for the past year. She has held leadership positions in human resources at TreeHouse Foods, ConAgra Foods, and Fiserv.

Mar 31, 2021

Sera Prognostics: Robert Harrison

Pregnancy test firm Sera Prognostics has appointed Robert Harrison as chief information officer. For more than three decades, Harrison has served in senior leadership positions of both public and private companies. Most recently, he served as officer of Myriad Genetics' chief information office. With Myriad Genetics, he directed the information technology integration of four strategic acquisitions and helped facilitate its international business expansion over the past decade. Harrison is a member of the Association for Information Management Utah CIO Council and is a long-standing board member of the Utah Technology Council.

Mar 30, 2021

Paige: Andy Moye, Juan Antonio Retamero

Paige has appointed Andy Moye its chief commercial officer and Juan Antonio Retamero its medical director. Moye has been the head of commercial operations in North America and Latin America for Philips and has held executive roles at companies including Ontada, a division of McKesson, Caris Life Sciences, and WaferGen Biosystems, now part of Takara Bio. Retamero is a pathologist and expert on the use of digital pathology tools for routine clinical diagnosis. He will lead New York-based development strategy and relationships with clinical and health economic leaders.

Mar 30, 2021

Flatiron Health: Carolyn Starrett

Roche subsidiary Flatiron Health announced that Carolyn Starrett, the current leader of the company's oncology business, will take over as CEO effective April 16. She will replace CEO and Cofounder Nat Turner, who is stepping down from Flatiron management. 

Starrett joined the company in 2016 and was previously VP of customer experience and operations at Flatiron. She served as VP of partnerships and business operations and VP of strategic partnerships at Intent Media before joining Flatiron. 

She has also served as a consultant at Boston Consulting Group and as a senior product manager at Jupiter Networks. 

Mar 30, 2021

VolitionRx: Kim Nguyen, Richard Brudnik

VolitionRx announced that Kim Nguyen and Richard Brudnik had been appointed to the company's board of directors, with Nguyen appointed chair of the company's compensation committee and as a member of the nominations and governance committee. Brudnick was appointed as a member of the audit and compensation committees. 

Nguyen is the head of human relations for Google Asia Pacific, covering the tech and portfolio businesses. She has 20 years of global HR experience.

Brudnick is the chief business officer and head of corporate strategy at Codiak BioSciences, a biopharmaceutical company focused on exome-based therapeutics. He has previously served in senior portfolio strategy, corporate development, and business development positions at pharmaceutical companies.